Search Results - "Greig, Iain R"
-
1
The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators
Published in Journal of medicinal chemistry (23-05-2019)“…The first generation of CB1 positive allosteric modulators (e.g., ZCZ011) featured a 3-nitroalkyl-2-phenyl-indole structure. Although a small number of drugs…”
Get full text
Journal Article -
2
Genomic and non-genomic pathways are both crucial for peak induction of neurite outgrowth by retinoids
Published in Cell communication and signaling (02-05-2019)“…Retinoic acid (RA) is the active metabolite of vitamin A and essential for many physiological processes, particularly the induction of cell differentiation. In…”
Get full text
Journal Article -
3
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Published in Nature medicine (01-07-2005)“…Accelerated osteoclastic bone resorption has a central role in the pathogenesis of osteoporosis and other bone diseases. Identifying the molecular pathways…”
Get full text
Journal Article -
4
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Published in Neuropsychopharmacology (New York, N.Y.) (01-12-2015)“…The CB1 receptor represents a promising target for the treatment of several disorders including pain-related disease states. However, therapeutic applications…”
Get full text
Journal Article -
5
Effects of glycol-split low molecular weight heparin on placental, endothelial, and anti-inflammatory pathways relevant to preeclampsia
Published in Biology of reproduction (01-11-2018)“…Low molecular weight heparin (LMWH) is being investigated as a potential preventative therapy against preeclampsia. There is evidence suggesting that LMWH may…”
Get full text
Journal Article -
6
Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids
Published in The Journal of biological chemistry (02-01-2012)“…GPR55 is activated by l-α-lysophosphatidylinositol (LPI) but also by certain cannabinoids. In this study, we investigated the GPR55 pharmacology of various…”
Get full text
Journal Article -
7
Motor-like Tics are Mediated by CB2 Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex
Published in Molecular neurobiology (01-08-2022)“…Δ 9 -Tetrahydrocannabinol (Δ 9 -THC) inhibits tics in individuals with Tourette syndrome (TS). Δ 9 -THC has similar affinities for CB 1 /CB 2 cannabinoid…”
Get full text
Journal Article -
8
Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators
Published in Bioorganic & medicinal chemistry letters (15-09-2016)“…[Display omitted] Existing CB1 negative allosteric modulators (NAMs) fall into a limited range of structural classes. In spite of the theoretical potential of…”
Get full text
Journal Article -
9
Antidepressant activity of pharmacological and genetic deactivation of the small-conductance calcium-activated potassium channel subtype-3
Published in Psychopharmacology (2022)“…Rationale The voltage-insensitive, small-conductance calcium-activated potassium (SK) channel is a key regulator of neuronal depolarization and is implicated…”
Get full text
Journal Article -
10
Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro
Published in Calcified tissue international (01-03-2008)“…Bisphosphonates are widely used for the treatment of bone diseases associated with increased osteoclastic bone resorption. Bisphosphonates are known to inhibit…”
Get full text
Journal Article -
11
A novel allosteric modulator of the cannabinoid CB1 receptor ameliorates hyperdopaminergia endophenotypes in rodent models
Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2021)“…Abstract The endocannabinoid system (eCBs) encompasses the endocannabinoids, their synthetic and degradative enzymes, and cannabinoid (CB) receptors. The eCBs…”
Get full text
Journal Article -
12
Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy
Published in Journal of medicinal chemistry (13-04-2017)“…We designed and synthesized perhexiline analogues that have the same therapeutic profile as the parent cardiovascular drug but lacking its metabolic liability…”
Get full text
Journal Article -
13
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
Published in Behavioural pharmacology (01-04-2014)“…Several allosteric modulators (AMs) of the CB1 receptor have been characterized in vitro, including Org27569, which enhances CB1-specific binding of…”
Get full text
Journal Article -
14
Synthesis and structure-activity relationship studies of novel tubulysin U analogues--effect on cytotoxicity of structural variations in the tubuvaline fragment
Published in Organic & biomolecular chemistry (14-04-2013)“…Tubulysins are cytotoxic natural products with promising anti-cancer properties, originally isolated from myxobacterial cultures. Structurally, tubulysins are…”
Get more information
Journal Article -
15
The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB 1 Receptor Positive Allosteric Modulators
Published in Journal of medicinal chemistry (23-05-2019)“…The first generation of CB positive allosteric modulators (e.g., ZCZ011) featured a 3-nitroalkyl-2-phenyl-indole structure. Although a small number of drugs…”
Get full text
Journal Article -
16
In Vitro Characterization of 6‑Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl‑1H‑indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?
Published in ACS pharmacology & translational science (09-12-2022)“…Orthosteric activation of CB1 is known to cause a plethora of adverse side effects in vivo. Allosteric modulation is an exciting therapeutic approach and is…”
Get full text
Journal Article -
17
Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in mice
Published in Annals of the rheumatic diseases (01-01-2015)“…Inflammatory joint diseases such as rheumatoid arthritis are associated with local bone erosions and systemic bone loss, mediated by increased osteoclastic…”
Get more information
Journal Article -
18
Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis
Published in Science advances (08-12-2023)“…While most research and treatments for multiple sclerosis (MS) focus on autoimmune reactions causing demyelination, it is possible that neurodegeneration…”
Get full text
Journal Article -
19
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1 H -indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?
Published in ACS pharmacology & translational science (09-12-2022)“…Orthosteric activation of CB is known to cause a plethora of adverse side effects . Allosteric modulation is an exciting therapeutic approach and is hoped to…”
Get full text
Journal Article -
20
Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of Anthelmintics
Published in ACS infectious diseases (13-07-2018)“…The enormous prevalence of infections caused by parasitic nematodes worldwide, coupled to the rapid emergence of their resistance to commonly used anthelmintic…”
Get full text
Journal Article